Please assess the completion status of the following clinical trial:

Trial Title: Short Versus Long Interval to Ileostomy Reversal After Ileal Pouch Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Signed informed consents.~* Man or woman between 18 and 64 years of age.~* Ulcerative colitis (UC) or indeterminate colitis (IC) diagnosed by routine clinical, radiographic, endoscopic, and pathological criteria.~* Patient will be scheduled for non-emergent proctocolectomy or completion proctectomy with ileal j-pouch anal anastomosis (IPAA) and loop ileostomy (IPAA).~* Clinical assessment of patient after IPAA surgery indicates that patient is suitable for early ileostomy reversal~Exclusion Criteria:~* Age \< 18 or \> 64 years~* Colon or rectal cancer~* Crohn's disease or suspected Crohn's disease~* Prednisone dose \> 20 mg per day (or equivalent other steroid dose) within 4 weeks of scheduled IPAA~* Body mass index (BMI) equal to or greater than 40 kg/m2~* Hemodynamic instability (persistent pulse rate \< 50 or \> 120 bpm, systolic blood pressure \< 90 or \> 160 mm Hg, uncontrolled cardiac arrhythmia, or active vasopressor drug use)~* Organ transplant recipient (e.g. Liver, Kidney, Pancreas)~* Immunosuppression due to chemotherapy drug use or systemic disease.~* Sepsis~* Renal insufficiency (i.e. serum creatinine ? 2 mg/dl or need for dialysis)~* Therapeutic anticoagulation (e.g. venous thromboembolic disease, prosthetic heart valve)~* Blood Hemoglobin \< 8 g/dl~* Serum Albumin \< 2.5 g/dl~* Individualized decision by the surgeon to exclude the patient based on sound surgical judgment~* Pregnant patients and female patients who do not satisfy the standard of care requirements of participating centers for an elective surgical procedure.~* Clinical assessment of patient after IPAA surgery indicates that patient is not suitable for early ileostomy reversal~* Participation in another clinical trial within the last 30 days, or simultaneous participation in another clinical trial~* Well-founded doubt about the patient's cooperation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- Early ileostomy closure (Type: EXPERIMENTAL): Early ileostomy closure will be performed 7 to 12 days after with ileal j-pouch anal anastomosis (IPAA) and loop ileostomy (IPAA).
- Late ileostomy closure (Type: ACTIVE_COMPARATOR): Late ileostomy closure will be performed 8 - 12 weeks after IPAA.

Based on this trial design, predict the completion outcome and termination type (if applicable).